Literature DB >> 8983677

Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein grafts one year after aortocoronary bypass surgery.

T Hozumi1, J Yoshikawa, K Yoshida, T Akasaka, T Takagi, Y Honda, H Okura.   

Abstract

OBJECTIVE: To use intravascular ultrasound in vivo to evaluate changes in the intimal thickness of angiographically normal saphenous vein grafts one year after implantation.
DESIGN: Fifteen saphenous vein grafts in 12 patients were examined one month and 12 months after aortocoronary bypass graft surgery with intravascular ultrasound using a 30 MHz transducer. None of the grafts examined showed any angiographic abnormalities. The intimal thickness and intimal area of the graft in the proximal portion were measured on intravascular ultrasound images obtained one month and 12 months after operation.
SETTING: General hospital. PATIENTS: Twelve patients who underwent aortocoronary bypass graft surgery.
RESULTS: The ultrasound images showed a thin-walled graft with a thin intima one month after operation (mean (SD)) (0.31 (0.09) mm). The intimal thickness of the graft increased significantly to 0.65 (0.08) mm (P < 0.001) 12 months after operation. The intimal area of the graft was 0.90 (0.80) mm2 one month after operation. 12 months after operation the intimal area had increased significantly to 5.26 (1.38) mm2 (P < 0.001).
CONCLUSION: Intravascular ultrasound in vivo showed that one year after implantation angiographically normal saphenous vein grafts had a thicker intima than one month after implantation.

Entities:  

Mesh:

Year:  1996        PMID: 8983677      PMCID: PMC484542          DOI: 10.1136/hrt.76.4.317

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Vein graft patency and intimal proliferation after aortocoronary bypass: early and long-term angiopathologic correlations.

Authors:  G M Lawrie; J T Lie; G C Morris; H L Beazley
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

2.  Intravascular ultrasound to assess aortocoronary venous bypass grafts in vivo.

Authors:  S Nase-Hueppmeier; R Uebis; R Doerr; P Hanrath
Journal:  Am J Cardiol       Date:  1992-08-15       Impact factor: 2.778

3.  Changes in saphenous veins used as aortocoronary bypass grafts.

Authors:  T L Spray; W C Roberts
Journal:  Am Heart J       Date:  1977-10       Impact factor: 4.749

4.  Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively.

Authors:  J T Lie; G M Lawrie; G C Morris
Journal:  Am J Cardiol       Date:  1977-12       Impact factor: 2.778

5.  Pathologic changes in aortic-coronary arterial saphenous vein grafts.

Authors:  Z Vlodaver; J E Edwards
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

Review 6.  Quantitative computer techniques for analyzing coronary arteriograms.

Authors:  B G Brown; E L Bolson; H T Dodge
Journal:  Prog Cardiovasc Dis       Date:  1986 May-Jun       Impact factor: 8.194

7.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

Review 8.  Visual estimates of percent diameter coronary stenosis: "a battered gold standard".

Authors:  M L Marcus; D J Skorton; M R Johnson; S M Collins; D G Harrison; R E Kerber
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

9.  Comparison of angiographic and postmortem findings in patients with coronary artery disease.

Authors:  J N Schwartz; Y Kong; D B Hackel; A G Bartel
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

10.  Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery.

Authors:  S H Smith; J C Geer
Journal:  Arch Pathol Lab Med       Date:  1983-01       Impact factor: 5.534

View more
  10 in total

1.  A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.

Authors:  Olivier F Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence Title; Vladimir Dzavik; Madhu Natarajan; Juan Angel; Nuria Batalla; Natalie Alméras; Olivier Costerousse; Robert De Larochellière; Louis Roy; Jean-Pierre Després
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

2.  The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].

Authors:  Alexander Kulik; Michel Le May; George A Wells; Thierry G Mesana; Marc Ruel
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-10-11

3.  Neointima development in externally stented saphenous vein grafts.

Authors:  Przemysław Węglarz; Michał Krejca; Maria Trusz-Gluza; Krystyna Bochenek; Ewa Konarska-Kuszewska; Krzysztof Szydło; Piotr Kuszewski; Christopher L Jackson; Gianni D Angelini; Grzegorz Bajor
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

4.  A comparison of postoperative morphometric and hemodynamic changes between saphenous vein and left internal mammary artery grafts.

Authors:  Tingting Fan; Yundi Feng; Feng Feng; Zhongjie Yin; Dayou Luo; Yuan Lu; Yingjin Xu; Wenchang Tan; Yunlong Huo
Journal:  Physiol Rep       Date:  2017-11

5.  Early Stage of Atherosclerosis in Aortocoronary Saphenous Vein Grafts: Intravascular Ultrasound Study.

Authors:  Przemysław Węglarz; Tomasz Bochenek; Grzegorz Bajor; Katarzyna Mizia-Stec; Michał Krejca; Maria Trusz-Gluza
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

6.  Morphological Lesion Types Are Associated with Primary and Secondary Patency Rates after High-Pressure Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas.

Authors:  Li Chen; Weichen Zhang; Jinyun Tan; Min Hu; Weihao Shi; Minmin Zhang; Yong Wang; Bo Yu; Jing Chen
Journal:  Blood Purif       Date:  2021-07-28       Impact factor: 3.348

7.  Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts.

Authors:  Ute Reisinger; Stefan Schwaiger; Iris Zeller; Barbara Messner; Robert Stigler; Dominik Wiedemann; Tobias Mayr; Christoph Seger; Thomas Schachner; Verena M Dirsch; Angelika M Vollmar; Johannes O Bonatti; Hermann Stuppner; Günther Laufer; David Bernhard
Journal:  Cardiovasc Res       Date:  2009-02-19       Impact factor: 10.787

8.  Low Wall Shear Stress Is Associated with Saphenous Vein Graft Stenosis in Patients with Coronary Artery Bypass Grafting.

Authors:  Muhammad Owais Khan; Justin S Tran; Han Zhu; Jack Boyd; René R Sevag Packard; Ronald P Karlsberg; Andrew M Kahn; Alison L Marsden
Journal:  J Cardiovasc Transl Res       Date:  2020-04-02       Impact factor: 3.216

Review 9.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound.

Authors:  Gavin J Murphy; Gianni D Angelini
Journal:  Cardiovasc Ultrasound       Date:  2004-07-21       Impact factor: 2.062

10.  Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.

Authors:  David P Taggart; Carolyn M Webb; Anthony Desouza; Rashmi Yadav; Keith M Channon; Fabio De Robertis; Carlo Di Mario
Journal:  J Cardiothorac Surg       Date:  2018-11-19       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.